Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mesangial matrix is a specialized extracellular matrix (ECM) located within the renal glomerulus that provides essential structural support to the capillary loops and modulates the glomerular filtration surface area. It is primarily composed of proteins such as Type IV and V collagens, laminin, and fibronectin, which are synthesized and maintained by resident mesangial cells. In addition to its structural role, the matrix serves as a reservoir and signaling hub for various cytokines and growth factors, including Transforming Growth Factor-beta (TGF-beta), Platelet-Derived Growth Factor (PDGF), and tumor necrosis factor-alpha (TNF-alpha). Under pathological conditions like diabetic nephropathy or lupus nephritis, these cytokines drive an imbalance in matrix homeostasis, leading to excessive ECM deposition and mesangial expansion. This expansion eventually results in glomerulosclerosis and progressive loss of kidney function. Therapeutic interventions often target specific signaling components within this environment, such as TGF-beta or PDGF receptors, to inhibit the profibrotic and inflammatory cascades that characterize chronic kidney disease.
Mechanisms include the inhibition of profibrotic signaling (TGF-beta/Smad pathway), blockade of mitogenic growth factor receptors (PDGFR), and reduction of inflammatory cytokine production to prevent pathological extracellular matrix accumulation and mesangial cell hypertrophy.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mesangial matrix and its cytokines.